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Spray dryingAbstract Poor solubility and bioavailability of an existing or newly synthesized drug always pose
challenge in the development of efﬁcient pharmaceutical formulation. Numerous technologies can
be used to improve the solubility and among them amorphous solid dispersion based spray drying
technology can be successfully useful for development of product from lab scale to commercial scale
with a wide range of powder characteristics. Current review deals with the importance of spray dry-
ing technology in drug delivery, basically for solubility and bioavailability enhancement. Role of
additives, selection of polymer, effect of process and formulation parameters, scale up optimization,
and IVIVC have been covered to gain the interest of readers about the technology. Design of exper-
iment (DoE) to optimize the spray drying process has been covered in the review. A lot more
research work is required to evaluate spray drying as a technology for screening the right polymerKrislon
bhashis.
Revealing facts behind spray dried solid dispersion technology used for solubility enhancement 353for solid dispersion, especially to overcome the issue related to drug re-crystallization and to achieve
a stable product both in vitro and in vivo. Based on the recent FDA recommendation, the need of
the hour is also to adopt Quality by Design approach in the manufacturing process to carefully opti-
mize the spray drying technology for its smooth transfer from lab scale to commercial scale.
ª 2013 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.Contents
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In recent times, many new chemical entities (NCEs) have been
synthesized on the basis of structure of their target receptors
using combinatorial chemistry, which results in the invention
of very large molecules with greater degree of hydrophobicity.
Their poor aqueous solubility may cause poor solubilization in
the gastrointestinal tract with low and unpredictable bioavail-
ability (Shukla et al., 2011). It is frequently documented that
almost 40% of NCEs discovered by the pharmaceutical
researchers are poorly soluble or lipophilic in nature (Giri
et al., 2010). The solubility performance of drugs remains
one of the most challenging qualities in formulation develop-
ment and it results in challenge in targeted delivery of poorly
water soluble drugs (Kumar et al., 2011). Solid dispersion is
one of methods which involves dispersion of one or more ac-
tive ingredients in an inert carrier or matrix in solid state pre-
pared by melting, dissolution in solvent or solvent evaporation
method (Verma et al., 2011). Solid dispersion based spray dry-
ing technology is widely applied in pharmaceutical industry be-
cause it is simple, economic and advantageous (Patel and
Patel, 2012; Hite et al., 2003; Mohanachandran et al., 2010).
This review article covers an overview of spray drying technol-
ogy, critical process parameters (CPPs) and their effect in ﬁnal
product quality, effect of various additives in spray drying,
screening methodology for selection of suitable carrier poly-
mer, scale up in spray drying and in vitro–in vivo correlation
(IVIVC) of spray dried formulation. Quality by Design(QbD) is also an important aspect in optimization of the spray
drying process parameters to assure the desirable reproducibil-
ity and quality of ﬁnal product; therefore, it has also been cov-
ered under this review.2. Various methods to overcome solubility issue
As shown in Table 1, various physical and chemical methods
can be used to improve the solubility of poorly water soluble
drugs. Particle size reduction is one of the physical methods
to enhance solubility, but sometime decreasing the particle size
may cause the agglomeration, which may retard the solubility
and bioavailability during storage of ﬁnal product. Presenting
the compound as a molecular dispersion combines the beneﬁts
of a local increase in the solubility as well as stability of amor-
phous form of drug (Pouton, 2006; Leuner and Dressman,
2000). Selection of right carrier polymer is also vital to im-
prove solubility and stability, so screening right excipient for
solid dispersion technology has also been covered in the cur-
rent review. As shown in Fig. 1, absorption of a BCS class II
drug can be signiﬁcantly improved by optimization of the
formulation in such a way that it maintains class II drugs in
a solubilized condition at the absorption site and due to that
it gives a similar absorption proﬁle like that of a class I mole-
cules. For BCS class III and IV molecules, the permeability
and absorption can be improved by means of chemical modi-
ﬁcation during the drug synthesis (Pouton, 2006).
Figure 1 Bio pharmaceutics (BCS) classiﬁcation (modiﬁed from Pouton, 2006).
Table 1 List of technologies to improve the solubility of poorly soluble drugs (Kumar et al., 2011; Patel and Patel, 2012; Leuner and
Dressman, 2000).
Physical methods Chemical modiﬁcation
Particle size reduction (micronization or nanosuspensions) Salt formation
Polymorphism Prodrug approach
Change in crystal habit
Complexation/solubilization (use of surfactants or use of cyclodextrines)
Drug dispersion in carriers (solid dispersions)
354 B.B. Patel et al.3. Solid dispersion technology
Solid dispersion is deﬁned as the dispersion of one or more ac-
tive ingredients in an inert excipient or matrix (carrier), where
the active ingredients could exist in ﬁnely crystalline, solubi-
lized or amorphous state (Sareen et al., 2012; Kapoor et al.,
2012). Solid dispersion consists of two or more than two com-
ponents, generally a carrier polymer and drug along with sta-
bilizing agent (and/or surfactant or other additives). The most
important role of the added polymer in solid dispersion is to
reduce the molecular mobility of the drug to avoid the phase
separation and re-crystallization of drug during storage. The
increase in solubility of the drug in solid dispersion is mainly
because drug remains in amorphous form which is associated
with a higher energy state as compared to crystalline counter-
part and due to that it required very less external energy to dis-
solve (Duarte et al., 2011). Additionally, formation of small
particle size with better porosity, wettability and surface area
are the main reasons for the improvement in bioavailability
(Vasconcelos et al., 2007).
There are basically two types of solid dispersion systems:
crystalline and amorphous solid dispersions (Dhirendra
et al., 2009; Calahan, 2011). Former system contains the
crystalline drug dispersed within a crystalline or semi-crystal-
line carrier. Later system contains a carrier which is
amorphous rather than crystalline, and it can be additionally
classiﬁed into solid crystalline suspension, solid glassy sus-
pension, and solid glassy solution (Baird and Taylor,
2012). As shown in Fig. 2, solid glassy solutions containing
drug and carrier are homogeneous and molecularly dispersed
with each other in single homogeneous phase and in
differential scanning calorimetry (DSC), it shows single glasstransition temperature (Tg) peak. Solid glassy solution is the
best system to achieve solubility enhancement with good
thermal and physical stability. Two phase blends also known
as solid glassy suspensions contain drug in partially miscible
state with the carrier and are more prone to undergo phase
separation during storage. Solid crystalline suspension con-
tains polymer in amorphous phase while drug in crystalline
phase and in DSC it shows one Tg peak for polymer and
one melting peak for drug which indicates no miscibility be-
tween drug and the polymer. To accomplish the substantial
stability of solid dispersion, pharmaceutically suitable carri-
ers like polymers, surfactants and stabilizers are added into
the formulation, usually at high concentrations to reduce the
molecular mobility and re-crystallization of drug (Baird and
Taylor, 2012).
4. Screening of polymer in solid dispersion technology
With the aim to accomplish the desired solubility and stability of
amorphous form of drugs, selection of right polymer(s) or car-
rier(s) is required in the initial stage of formulation develop-
ment. Excipient screening or selection would be time-
consuming and requires an extra labor with consumption of a
large amount of drug. In the early phase of lead optimization
and candidate selection, large numbers of hydrophobic com-
pounds are synthesized in very small quantities and, therefore
well efﬁcient polymer screening method is required which
consumes minimum amount of drug (Dai et al., 2008; Gheb-
remeskel et al., 2007).
Dai and co-workers have developed experimentation ap-
proaches to rapidly identify a solubility-enhancing polymer
that improved the bioavailability of a poorly water-soluble
Figure 2 Types of solid dispersion.
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panel of excipients were dissolved in common organic
solvent like n-propanol and distributed into the wells of a
96-well micro titer plate by a TECAN (innovative liquid
handling workstation) robot. After solvent evaporation, the
dried formulations were further diluted with an aqueous buf-
fer and incubated for 24 h and the solubilization capacity of
the excipients was analyzed by HPLC (Dai et al., 2007).
Moreover, the optimized formulation can be scaled up and
developed using various methods like hot melt extrusion
or spray drying to compare the actual solubility and screen-
ing experimental solubility (Shanbhag et al., 2008). Barillaro
and co-workers have also evaluated total 108 experiments
containing 7 different polymers and 5 different surfactants
to study the dissolution property of phenytoin (Barillaro
et al., 2008). Similarly, Mansky and team have also devel-
oped in house and well efﬁcient screening method to identify
lipid and semisolid formulations for low soluble compounds
(Masky et al., 2007). The limitation of all the above men-
tioned methods is that it requires consumption of drug
and requires extra labor for analytical study to identify suit-
able polymer. So, various pharmaceutical companies, service
provider and excipient manufacturer companies are working
on various novel approaches for improving solubility of
poorly soluble drugs using solid dispersion technology (Ar-
num, 2012).5. Background of spray drying technology
Spray drying technology can be deﬁned as a unit operation
in which a liquid stream (solution, suspension or emulsion)
is constantly divided into very ﬁne droplet (by a process
known as atomization) into a glass compartment where they
come in contact with hot gas and get dried into ﬁne parti-
cles, which are further separated from the drying gas using
a cyclone or a bag-ﬁlter (Paudel et al., 2012). Spray driers
can operate in open cycle mode for aqueous based or in
closed-loop mode for organic based system. Spray drying
is a moderate drying technique (where gentle temperatures
and little exposure times are used as compared to other solid
dispersion technology like melt extrusion) that yields powder
with reasonable particle size (Patel et al., 2009; Vehring,
2008). Moreover, the fast drying process within few seconds
or milliseconds is also important to prevent phase separation
between the drug and polymer components (Duarte et al.,
2011).6. Selection of carrier polymer in spray drying based solid
dispersion technology
Selection of carrier in spray drying has a signiﬁcant effect on
stability of amorphous form of drug during in vitro and in vivo
356 B.B. Patel et al.condition. There are numerous factors which need to be evalu-
ated before carrier polymer selection like: glass transition tem-
perature (Tg) of polymer, nature of polymer (anionic/cationic)
and presence of functional group, hygroscopicity of polymer,
solubility in common organic solvent, thermal stability, etc.
Some polymers work as awetting agent to solubilize the released
drug, whereas others will also help to stabilize the supersatu-
rated drug solution (Mooter, 2011). The existence of useful moi-
eties like hydrogen donors or acceptors is a surplus advantage
which helps to inhibit crystallization of a drug from a glass solu-
tion. Generally physical instability or nucleation occurs below
Tg of polymer due to higher molecular mobility, so polymer
with higher Tg value is usually preferred in solid dispersion to
improve shelf life of ﬁnal formulation (Vasconcelos et al.,
2007; Mooter, 2011). Polymers can boost the physical stability
of system by increasing the Tg of miscible mixtures and for that
it should be also molecularly miscible with drug (Vasconcelos
et al., 2007). There are numerous carriers like enteric polymers,
hydrophilic polymers, amphiphilic polymers and surfactants are
used in spray drying technology and is highlighted in Table 3.
Kanno and Taylor (2006) have evaluated three different carrier
polymers mainly poly(vinylpyrrolidone) (PVP), hydroxypropyl
methylcellulose (HPMC) and hydroxypropyl methylcellulose
acetate succinate (HPMCAS) for solubility enhancement of
Felodipine via the solvent evaporation method. They have ob-
served that HPMCAS was found to sustain the highest level of
supersaturation for the maximum length of time during both
dissolution and solution crystallization experiments, whereas
PVP was found to be the least effective crystallization inhibitor.
They have concluded that HPMCAS and HPMC were most
effective at inhibiting growth rates while PVP was much less
effective (Kanno and Taylor, 2006). So, the role of polymer is
not only to stabilize drug against crystallization in the solid state
but it should also improve the dissolution proﬁle by inhibiting
crystallization from the supersaturated solution generated by
dissolution of the amorphous material.Table 2 Critical process parameters (CPP) and their inﬂuence in
Technical Documents).
S. No CPP Signiﬁcance in
1 High aspirator rate 1. Due to mo
2. Residual m
3. Offers mo
2 High solid content or high viscosity 1. Less liquid
2. Due to mo
3. Produces
4. Decreases
3 High drying gas humidity 1. Moist par
2. Might inc
4 High feed rate 1. Decreases
2. Increases
3. Increases
5 High spray gas ﬂow 1. Decreases
2. Produces
6 High inlet temperature 1. It increase
2. Increases
7 Use of organic solvent 1. Use of org7. Critical process and formulation parameters in spray drying
technology
Table 2 and Figs. 3 and 4 show effect of critical process and
formulation parameters like spray rate, outlet temperature, so-
lid concentration, atomization rate, etc., on the product char-
acteristics of spray drying technology. These parameters in
detail have been discussed below.7.1. Selection of solvent(s) and feed rate for spray drying
technology
In order to make uniform and stable solid dispersions, the
choice of solvent should be selected very carefully for solvent
based spray dryer because spray dryers are generally sized
based on their evaporative capability for a particular solvent.
In general, lower boiling solvents are very easy to evaporate
and it results in higher solid production yield (Paudel et al.,
2012). Drug dissolution rates can be greatly inﬂuenced by drug
concentration in the feed solution, the choice of polymer,
choice of surfactant and the ratio of polymer/surfactant/drug
(Huntington, 2004). Feed solution can be a reactive system
and must be evaluated in terms of impurity levels over a num-
ber of days due to possible chemical reaction of drug with sol-
vents and additives (Wu et al., 2011; Paudel and Mooter,
2012). Solvent selection should be carried out on the basis of
following criteria like: boiling point, solubility of drug and
polymer and toxicity of solvent on the basis of ICH classiﬁca-
tion (like class III solvents are more selected as compared to
class I solvent due to less toxicity potential) (ICH, 2011a,b).
In Tables 3 and 4 possible carriers as well as commonly used
solvents for spray drying technology have been enlisted
(ICH, 2011a,b; Mahapatra et al., 2012; Shi et al., 2012; Hugo
et al., 2013).spray drying process (modiﬁed from Behera et al., 2010, Buchi
spray drying process
re drying energy the outlet gas temperature may increase
oisture in the ﬁnal product may decrease
re and uniform separation of particles in the cyclone
to vaporize and increase exhaust temperature
re solid in a drop may increase the particle size
bigger particles, which are easier to separate and increases yield
the moisture level in ﬁnal product
ticles may adhere into the glassware and decreases process yield
rease the humidity in ﬁnal product
the outlet temperature
the droplet size and subsequently particle size
the moisture level in the ﬁnal product
the outlet temperature
smaller droplets from nozzle and parallel particle size decreases
s the outlet temperature proportionally
the yield and gives less sticky product
anic solvent generates smaller particles due to lower surface tension
Figure 4 Effect of process parameters in ﬁnal product characteristics (modiﬁed from Behera et al., 2010, Buchi Technical Documents).
Figure 3 Critical process and formulation variables in spray drying technology.
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Table 3 List of carriers used for solid dispersion technology (Duarte et al., 2011; Mahapatra et al., 2012; Shi et al., 2012).
Type of
carrier
Examples
Enteric
polymer
Methacrylate polymers (Eudragit E PO/100, Eudragit RLPO, Eudragit
L100, Eudragit S100), Hydroxypropyl methyl cellulose phthalate (HPMCP),
Cellulose acetyate phthalate (CAP)
Hydrophilic
polymers
Starch, Sodium Carboxymethyl cellulose, Sodium alginate, Polyethylene glycol
(PEG), Polyvinyl pyrollidone (PVP), Hydroxy propyl methyl cellulose
(HPMC), Polyvinyl alcohol (PVA), b-Cyclodextrin, Mannitol, Chitosan,
Carrageenan
Surfactant Polyethylene – polypropylene glycol, lecithin, bile salt, Lauroyl polyoxyl-32
glycerides
Amphiphilic
polymers
Polyethylene oxides (PEO)/Polypropylene glycol (PPG) copolymers, PEG-
modiﬁed starches, Vinyl acetate/vinylpyrrolidone random copolymers,
Polyacrylic acid and Polyacrylates
Table 4 List of commonly used solvents in spray drying technology (ICH, 2011a,b; Hugo et al., 2013).
List of solvents Boiling point (C) Dielectric constant Solubility in water (g/100 g) Density (g/ml) ICH limit (ppm)
Acetone 56.2 20.7 Miscible 1.049 Class 3
Chloroform 61.7 4.81 0.795 1.498 60
Methanol 64.6 32.6 Miscible 0.791 3000
Methylene chloride 39.8 9.08 1.32 1.326 600
Ethanol 78.5 24.6 Miscible Class 3
Dimethyl formamide (DMF) 153 36.7 Miscible 0.944 880
Dimethyl sulfoxide (DMSO) 189 47 25.3 1.092 Class 3
Glycerin 290 42.5 Miscible 1.261 –
Ethyl acetate 77 6 8.7 0.895 Class 3
Water 100 78.54 – 0.998 –
358 B.B. Patel et al.Dielectric constant of solvent is also one of the important
criteria for suitable solvent selection in spray drying process
because solubility of solute into solvent is dependent on the
dielectric constant of the medium. In simple terms, the energy
required to separate two oppositely charged bodies is inversely
proportional to the dielectric constant of the medium (Behera
et al., 2010). The addition of a co-solvent can increase the sol-
ubility of hydrophobic molecules by reducing the dielectric
constant of the solvent. Moreover, water is a good solvent
for polar molecules due to its high dielectric constant (Behera
et al., 2010). Jouyban et al. (2004) had developed a simple
computational method for calculating dielectric constants of
solvent mixtures based on Redlich–Kister extension. They
found that the model can be applied to the experimental dielec-
tric constant of binary and ternary solvent mixtures at ﬁxed
and/or various temperatures and it showed accurate results.
Moreover, changes in dielectric constant of the medium have
a dominant effect on the solubility of the ionizable drug mainly
as higher dielectric constant can cause more ionization of the
drug and results in more solubilization (Fakhree et al., 2010).
In one of the research work, Al-obaidi et al. (2011) had
evaluated two different solvents’ combination for griseoful-
vin–PVP based spray drying technology. They observed that
solid dispersion prepared from acetone/methanol (150/150)
showed smaller size particles as compared to acetone/water
(185/85) solvent mixture. The viscosity of the spray drying
solution was lower for acetone–methanol (0.554 cP) than for
acetone–water (1.39 cP) and from that it would be anticipated
that a dispersion resulting from the less viscous solution hada quicker rate of evaporation and gives small particle size.
Likewise, Harjunen et al. (2002) have studied the effect of eth-
anol to water ratio in feed solution and they found that lactose
spray dried from pure ethanol was 100% crystalline while lac-
tose spray dried from pure water was 100% amorphous.
Esposito et al. (2005) have observed that low feed rate gives a
better result in terms of morphology of prednisolone microparti-
cles likemoisture level, small particle size and goodﬂowproperty.
Rattes and Oliveira (2007) have also found that slower dissolu-
tion is obtained at higher feed rate and is partly due to the increase
in the diameter of the atomized drops at high feed ﬂow rate which
generates a bigger particle with lower total surface area. So, phys-
icochemical characteristics of spraydried powder are signiﬁcantly
affected on the basis of selection of solvent, viscosity of feed solu-
tion, concentrationof solid in feed solution, feed rate, and to some
extent by solution surface tension.7.2. Role of feed atomization on spray dried product
characteristics
The aim of atomizer is to break down bulk liquid feed concen-
trate into ﬁne droplets in order to provide a very large surface,
to facilitate solvent evaporation and particle separations.
Atomizer is appropriately ﬁtted in the drying assembly along
with feed inlet to allow uniform mixing between feed solu-
tions and drying gas. The most common atomizers used in
pharmaceutical industry are two-ﬂuid nozzles (pneumatic
atomization), pressure nozzles (hydraulic atomization), rotary
Revealing facts behind spray dried solid dispersion technology used for solubility enhancement 359atomizers (rotating wheel atomization) and ultrasonic
atomizer (Rattes and Oliveira, 2007; Bittner and Kissel,
1999; Cal and Sollohub, 2010). The choice of atomizer depends
upon the properties of the feed and the dried product
speciﬁcation.
Current research scenario is much more focused toward the
use of four ﬂuid spray nozzle in spray drying process to over-
come the necessity of using common solvents for two drugs. In
one of the studies, Mizoe et al. (2007) have used 4-ﬂuid spray
nozzle containing spray drier for preparing drug-containing
microparticles of poorly water-soluble drugs ethenzamide
(EZ) and ﬂurbiprofen (FP). They found that the 4-ﬂuid nozzle
atomizer can overcome the problems of using a common sol-
vent for two drugs as it has two liquid and two gas passages,
which allows drug and carrier to be dissolved in separate sol-
vents. Similarly, Chen and co-workers have prepared amor-
phous solid dispersion by separately passing drug and
polymer solutions all the way through four-ﬂuid nozzle and
observed better performance in terms of effective distribution
of particles in lungs with enhanced absorption characteristics
as compared to the microparticles prepared from a single solu-
tion (Chen et al., 2008).
The particle size distribution obtained after traditional
spray drying process is not well controlled. So, in order to con-
trol the particle size and morphology electro hydro-dynamic or
electro-spraying (EHD) atomization is generally used in spray
drying process (Lastow et al., 2007). In the EHD based atom-
ization method, feed solution is ﬁrst pumped through a nozzle
and the nozzle is applied with a high potential difference. The
electrical ﬁeld formed causes the jet emitted from the nozzle to
disintegrate into mono dispersed droplets in the micrometer
range (Kuang et al., 2012). Recently, Kuang and co-workers
have studied about changing the voltage applied to the elec-
trodes on the particle size. They observed that particles fabri-
cated at a much lower voltage were of smaller diameter than
particles fabricated at higher voltage. EHD is also used to pro-
duce ﬁne particles of a complex structure which are hard to ob-
tain by other means (Ciach, 2007). So, electro spraying process
has a unique advantage to produce a narrow size distribution
under the inﬂuence of electrical forces which makes it more
suitable for many pharmaceutical applications (Yurteri et al.,
2010).
7.3. Effect of inlet/outlet temperatures on ﬁnal product
characteristics
Outlet air temperature is one of the most critical parameters
which exclusively affects the product morphology like particle
size, surface roughness, density, stickiness of particles, residual
solvent or moisture levels, product yield, etc. After performing
spray drying process, secondary drying of powder is generally
required to remove the excess residual solvent because, pres-
ence of solvents may plasticize the solid dispersion by increas-
ing molecular mobility and it results in the development of
crystal growth. Spray drying process carried out at a lower
outlet temperature gives a product with high residual solvent
levels and poor ﬂow property (Alexander and King, 1985;
Littringer et al., 2012; Maury et al., 2005a,b).
Mass et al. (2011) have prepared 15% aqueous solution
of mannitol and spray dried it at 3 different temperatures
i.e. 60 C, 90 C and 120 C (M60, M90, and M120). Theyobserved that at 60 C outlet temperature, mannitol particles
were more spherical without inside void spaces or hole
formation as compared to particles dried at 90 C and
120 C. They concluded that due to lower internal pressure ap-
plied by the evaporating liquid at 60 C than at 90 C and
120 C, giving the vapor sufﬁcient time to escape without rup-
turing the solid shell (Mass et al., 2011). Likewise, Paramita
and co-workers have also found that spray-dried powders at
higher outlet temperatures give higher percentages of hollow
particles (Paramita et al., 2010).
8. Effect of various formulation additives on product
characteristics
The development of solid dispersion is shifting toward the
addition of a third or even more components along with poly-
meric carrier (so called as ternary solid dispersion) to stabilize
the amorphous form of drug during storage. The most com-
monly used adjuvants are surfactants or co-solvents that are
added in the solid dispersion to improve the dissolution and
physical stability of drug by improving the wettability and
minimize the crystallization of drug during storage. Apart
from surfactant, glidants/drying agents are also added during
spray drying process to improve the ﬂow property and yield
of the powder and to minimize sticking tendency of particle
in spray drying chamber. Some other additives can also be
added in spray drying process like disintegrants, pH modiﬁers,
salt former, complexing agents, etc. (Mahdjoub et al., 2003;
Aejaz et al., 2010; Shinde et al., 2011; Maghraby and Alomrani,
2011; Rahmati et al., 2013).
8.1. Effect of silica on product characteristics
The use of colloidal silica can minimize the electrostatic charge
generation between powders with the spray dryer wall, leading
to increased yield as well as improved ﬂow property of powder.
Moreover, porous silica also works as adsorbents (which gives
more surface area) and plays a signiﬁcant role in solubility
enhancement (Mahajan et al., 2012). Planinsek et al. (2011)
have developed solid dispersion containing porous silica and
observed that porous silica plays a signiﬁcant role in solubility
enhancements. Pokharkar and team have also accomplished
that the stability of solid dispersion was signiﬁcantly improved
due to the addition of Aerosil 200 (Pokharkar et al., 2006).
Ambike and team have also found that silica was playing a sig-
niﬁcant role in the improvement of ﬂow property and stability
of low glass transition temperature (Tg) drug like Simvastatin
(Ambike et al., 2005). Similarly, Chauhan et al., 2005 have pre-
pared spray dried solid dispersion in the presence of Aerosil
200 as adsorbents and found improvement in dissolution rate
(even after 3 months storage) as well as bioavailability.
Numerous other research works have also been reported about
improvement in dissolution, process yield and stability after
addition of silica in spray drying feed solution (Martins
et al., 2011; Takeuchi et al., 2005; Shen et al., 2011).
8.2. Effect of lactose on product characteristics
Makai et al. (2008) have evaluated the effects of lactose on the
surface properties of microparticles prepared by a spray-drying
360 B.B. Patel et al.method. In this work, they compared three different formula-
tions of untreated microcrystals, alginate-based spray-dried
microparticles and alginate-based lactose containing spray-
dried microparticles of trandolapril. They observed faster dis-
solution for the sample containing lactose in comparison to
those samples containing alginate or alginate and lactose.
Moreover, they concluded that the application of lactose
caused a marked increase in the surface polarity of the parti-
cles which helps to increase the solubilization potential of
drug.
9. Effect of stabilizer on product characteristics
The amorphous form of drug has the highest free energy and
entropy which results in superior molecular motion compared
to the crystalline state (leading to higher apparent solubility
and dissolution rate). High internal energy and molecular
mobility of amorphous materials are also accountable for crys-
tallization during storage and it can be minimized by the addi-
tion of suitable and proper concentration of stabilizer (Yu,
2001; Laitinen et al., 2012). So, stabilization of amorphous
form of drug during storage is more important to improve
the dissolution and in vivo efﬁcacy of developed formulation.
In various research studies, scientists have used different stabi-
lizers or surfactants along with drug-polymer mixtures to im-
prove the stability of solid dispersion. Beck et al. (2013) have
recently used non-ionic surfactant Pluronic F127 as a stabilizer
for the HPMC based solid dispersion. They observed that the
addition of Pluronic F127 along with HPMC results in con-
trolling initial growth and suppression of agglomeration and
the optimal formulation results in faster and higher extent of
dissolution than a poorly stabilized suspension.
10. Scale-up in spray drying
Spray dryers in the pharmaceutical industry are available in a
wide range of scales: from lab scale to commercial scale which
is capable of handling several tons of material per day (Gil
et al., 2010). Comparison of spray dryer at laboratory, pilot
and commercial scales is shown in Table 5 (Thybo et al.,
2008; Gohel, 2009).Table 5 Comparison of spray dryer at laboratory, pilot and comm
Parameter Lab scale
Drying gas Nitrogen/air
Type of feed Aqueous/organic solutions,
Fit for injectables? Yes
Atomization
devices
Two-ﬂuid nozzle
Nominal drying
gas ﬂow (kg/h)
40
Feed ﬂow rate
(kg/h)
2.5
Outlet
temperature (C)
40–65
Evaporating
capacity (kg
water/h)
1
Typical batch
scale (kg)
0.01–0.500Proper optimization of process parameters using factorial
design is a very powerful tool to support the scale-up of spray
drying process to achieve the desired powder characteristics at
a larger scale. The use of process simulation tool can also give
robust processes, faster development at a lower cost and high
product quality (Dobry et al., 2009). Inﬂuence of four main
parameters like as inlet temperature, feed ﬂow rate, atomiza-
tion gas ﬂow rate and solid concentration in feed solution
should be evaluated properly in the lab scale development.
The effects need to be determined in terms of particle size,
morphology, residual solvent, crystallinity, yield and stability.
In order to accomplish the uniform particle size in production
scale, atomization gas ﬂow and feed rate also need to be opti-
mized (like high atomization gas ﬂow and low feed rate give
smaller particles in production scale spray dryer) (Thybo
et al., 2008). Selection of suitable nozzle type depends on the
target quality attributes and properties of feed solution. In
most pharmaceutical applications, pressure nozzles are pre-
ferred then two-ﬂuid nozzles, because they provide powders
with a narrow particle size distribution. In the literature, it
was also reported that the lab scale atomizers are typically
two-ﬂuid nozzle, which are replaced by a pressure nozzle in
the commercial scale to control the particle size (Arpagaus
and Schwatzbach, 2008; Schwatzbach, 2010).11. Characterization of amorphous solid dispersion after spray
drying process
Conversion of API from amorphous to crystalline form during
storage may result in solubility retardation. So, determination
of glass transition temperature of carrier, molecular mobility
of the drug and the rate and extent of drug crystallization,
etc., need to be evaluated accurately to study the effect of stor-
age on solubility of drug. A wide range of thermal analytical
techniques can be used for characterization of solid dispersion
and among it, differential scanning calorimetry (DSC) is gen-
erally available in many industrial and academic laboratories
(Baird and Taylor, 2012; Leuner and Dressman, 2000; Parad-
kar et al., 2004). A modest factor like presence of moisture in
DSC instruments can also affect the Tg of solid dispersion
which was previously reported by Crowley and Zograﬁercial scales (Thybo et al., 2008; Gohel, 2009).
Pilot scale Commercial scale
suspensions or emulsions
Yes Yes
Two-ﬂuid nozzle,
pressure nozzle
Two-ﬂuid nozzle,
pressure nozzle
80 1250
45 45–60
40–65 40–65
6 90
0.2–20 10–1000
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various solid dispersions and concluded that Tg was strongly
depressed by absorption of moisture. Kanno and Taylor
(2006) have also studied the plasticizing effect of the moisture
and they observed that in the absence of moisture, the Tg of
solid dispersion was increased toward the direction of the Tg
of the pure polymer. While, in the presence of moisture, the
Tg values of the dispersions were lower, which clearly indicate
that the presence of moisture enhances the molecular mobility
of polymer and reduces the Tg value in PVP based solid disper-
sion. Some other thermal analytical techniques like X-ray dif-
fractometry (XRD), hot stage microscopy (HSM) and NMR
are used for identiﬁcation of crystalline structure in solid dis-
persion. In XRD spectra, crystalline form of drug usually
shows sharp peaks as speciﬁc 2h angles while amorphous form
shows a halo peak and so both polymorphic forms can be eas-
ily differentiated from each other. Similarly, presence of single
Tg peak of polymer without sharp melting peak of drug in
DSC spectra for solid dispersion indicates that degree of crys-
tallinity is considerably reduced and the drug is present in
amorphous form (Bhinse, 2011).
12. Quality by Design (QbD) in spray drying
QbD can be deﬁned as to design a process in such a way that
the ﬁnal product meets all the predeﬁned speciﬁcations and
achieves desirable quality attributes. In recent times, there is
an increasing demand from regulatory authorities to imple-
ment QbD and design of experiment (DoE) methodology in
product development stage. Objective behind this initiative is
to understand the manufacturing processes together to achieve
ﬁnal product within predeﬁned excellence (Lebrun et al., 2012).
International Conference on Harmonization (ICH) has pub-
lished guidelines that ‘‘the aim of pharmaceutical development
is to design a quality product and its manufacturing process to
consistently deliver the intended performance of the product.
The information and knowledge gained from pharmaceutical
development studies and manufacturing experience provides
scientiﬁc understanding to support the establishment of the de-
sign space, speciﬁcations, and manufacturing controls’’. So,
identiﬁcation of critical quality attributes (CQA) and critical
process parameters (CPP) in spray drying is more needed to
study the effect of their variation on the quality of ﬁnal prod-
uct. FDA’s process analytical technology (PAT) initiative is
also one of the collaborative efforts and the aim of PAT is sim-
ilar in line with QbD to assure high product quality through
timely measurements of critical quality and performance attri-
butes of raw materials, in-process materials and ﬁnal products
(Yu et al., 2004).
By considering the complexity of spray drying process,
optimization of spray drying process parameters is quite chal-
lenging to achieve the desirable product. In one of the research
work, Amaro et al. (2011) have applied 24 factorial DoE and
studied various CPPs like inlet temperature, gas ﬂow rate, feed
solution ﬂow rate and feed concentration. They have evaluated
resulting powders in terms of yield, particle size (PS), residual
solvent content (RSC), speciﬁc surface area and outlet temper-
ature as CQA. They observed that the yield was increased with
a decrease in gas ﬂow and it remains unchanged with respect to
increasing or decreasing the inlet temperature. Similar obser-
vation was also further supported by Buchi documents thatlower gas ﬂow reduces atomization energy and produces larger
particles. Baldinger et al. (2012) had recently illustrated the
inﬂuence of CPP on CQA of spray-dried powders by applying
DoE and found that the full factorial design proved to be
unsuitable due to the non-linear inﬂuence of factors while
the composite face-centered design improved the quality of
the models and showed both linear and non-linear inﬂuence
of the parameters on the outcomes.
Prinn et al. (2002) and Maltesen et al. (2008) have found
that feed solution concentration has the higher impact than
gas ﬂow rate on process yield. Bu¨chi technical data also dem-
onstrated that gas ﬂow and feed solution concentration have a
largest inﬂuence on the resulting particle size. Lower gas ﬂow
reduces atomization energy and producing larger particles
(Stahl et al., 2002). Maury et al. (2005a,b) have shown that
the powder yield was increased at higher process temperatures,
due to improved droplet drying and reduced droplet/particle
deposition on the walls of the drying chamber. Particle size
is also one of the most important CQA in spray drying process
and there are a number of reports indicating that as gas ﬂow
decreases and feed concentration increases larger particles
are produced (Stahl et al., 2002; Al-Asheh et al., 2003; Tajber
et al., 2009).
Residual solvent content is also one of the important eval-
uation parameters in spray drying process as residual solvent
work as plasticizer to reduce the Tg and may convert amor-
phous form of dug to crystalline form during storage. Amaro
et al. (2011) have recently shown that with increasing inlet tem-
perature, more energy is supplied to the drying chamber lead-
ing to more efﬁcient solvent removal from the droplets which
reduces residual solvent in the powder. Maury and team have
observed that high feed rate generates more solvent vapor and
reduces the exhaust temperature leading to a less efﬁcient dry-
ing, hence higher residual solvent content (Maury et al.,
2005a,b). So, in order to achieve higher yield with less residual
solvent content, high outlet temperature is required.
Another important evaluation parameter in spray drying
process is the porosity and speciﬁc surface area (SSA) of
microparticles (Amaro et al., 2011). Porous microparticles
have potential advantages over non-porous materials as they
have less inter-particulate attractive forces with better ﬂow
characteristics, and exhibit smaller aerodynamic diameters
than their geometric diameters, facilitating greater deposition
in the lower pulmonary region, with improved efﬁciency
(Healy et al., 2008; Papelis et al., 2003). Amaro et al.
(2011) have shown that three major CPPs have a negative ef-
fects i.e. inlet temperature, feed rate and feed concentration,
indicating that when any of these factors decrease, particles
with higher surface area are produced. One major CPP has
a positive coefﬁcient i.e. gas ﬂow, giving particles with higher
surface area at higher levels. Cabral-Marques and Almeida
(2009) have also developed and characterized a beclometha-
sone:c-cyclodextrin complex and optimized the variables on
the spray-drying process to obtain a powder with the most
suitable characteristics for lung delivery. All of above re-
search work highlights the complexity of process and interac-
tion of spray drying process parameters in the ﬁnal quality of
product. So, proper design of experimental is required in
spray drying process to achieve powders with desirable char-
acteristics, i.e. high yield, uniform particle size, high surface
area and low residual solvent.
362 B.B. Patel et al.13. In vitro–in vivo correlation (IVIVC) of spray dried
formulation
After preparing amorphous solid dispersion by spray drying
technology, in vitro dissolution as well as animal or human
in vivo absorption study is required for complete understand-
ing. Poddar et al. (2011) have prepared solid dispersion of
ritonavir using polyvinyl pyrollidone vinyl acetate as a carrier
polymer for solubility enhancement. During in vitro dissolution
analysis, they observed that 95% of drug was released in 25 min
from solid dispersion while only 20% of drug was released in
60 min from physical mixture. In vivo bioavailability results
showed AUC (t-8 h) value of 59.62 lg/ml h for solid dispersion
compared with that of pure drug which was 8.08 lg/ml h. This
result suggested that the absorption rate of solid dispersion was
remarkably higher than pure drug and they concluded that pre-
pared solid dispersion could signiﬁcantly improve both the dis-
solution rate and bioavailability of ritonavir.
Patel et al. (2010) have prepared the solid dispersion of
fenoﬁbrate with poloxamer 407 using spray drying technology.
The spray dried particles were characterized for the in vitro dis-
solution studies and in vivo absorption studies and the results
showed that the dissolution rate and oral bioavailability of
the spray dried fenoﬁbrate/poloxamer 407 particles were sig-
niﬁcantly increased as compared to pure drug. They concluded
that improved particle wetting in the presence of the hydro-
philic surfactant (as evidenced by contact angle measurements)
seems to be the most important determinant for in vivo oral
bioavailability. Muttil et al. (2007) have prepared biodegrad-
able and inhalable microparticles containing anti-tuberculosis
drugs using spray drying technology. During in vivo studies
they found that drug concentrations in macrophages were
20 times higher when microparticles were inhaled rather than
drug solutions administered. Naikwade et al. (2009) have
investigated the in vivo efﬁcacy of budesonide (BUD) micro-
particles for pulmonary administration and found that devel-
oped formulations had extended half-life (14 h) compared to
conventional formulation (9 h) with one to four-fold improved
systemic bioavailability with excellent lung deposition.
14. Conclusion
The new molecules synthesized by various pharmaceutical
companies or even existing molecules from certain therapeutic
classes turn out to be of low aqueous soluble in most cases. So,
there is a need for a formulator to ﬁnd a solution though dif-
ferent formulation designs and among it amorphous solid dis-
persion approach has proven to overcome such solubility
issues of BCS class II and IV molecules. Out of various tech-
nologies to generate solid dispersion/solution, the spray drying
method is constantly gaining attention due to its ease of pro-
cessing thermo labile compounds, its ﬂexibility in terms of
wide application range and the ease on process control to
achieve ﬁnal powder characteristics in terms of particle size
distribution, ﬂow property, porosity, yield, etc. Major chal-
lenge for formulation scientist in spray drying technology is
to accomplish a long term stability of amorphous form of
drug. In order to achieve a long term stability, selection of
right polymeric carrier is required which can form a molecular
solid glassy solution by decreasing the molecular mobility of
the drug and due to that it reduces the re-crystallization ofdrug during storage. A deep insight into the critical process
parameters of the spray drying technology is important to ob-
tain the desired product quality. Carrier polymer is a critical
component in spray drying process because it not only in-
creases the solubility of poorly water soluble drug but also
plays a vital role in minimizing the crystallization of drug dur-
ing storage. Moreover, a proper understanding of various ther-
mo analytical methods like DSC and XRD is also very
important to understand the desired solid state characteristics
of solid dispersions.
Moreover, spray drying process involves interactions be-
tween various formulation variables (like feed concentration,
solvent type, type of polymer) and process conditions (drying
gas ﬂow rate, feed rate, outlet temperature, atomization rate)
which can signiﬁcantly inﬂuence the particle characteristics
(yield, particle size, residual solvent content, ﬂow property,
surface area and release proﬁle) of the solid dispersion. Based
on the recent FDA and ICH product development guidelines,
Quality by Design (QbD) should also be adopted in spray dry-
ing formulation development to achieve the product within
predeﬁned quality speciﬁcation. By considering the complexity
of spray drying process, factorial design models can also be put
together to optimize the CPP which can produce a powder
with suitable characteristics, i.e. high process yield, maximum
dissolution, uniform particle size with low residual moisture
content. It is also important to understand the factors
inﬂuencing scale up of spray drying process for easy
commercialization.References
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